Allogeneic hematopoietic cell transplantation after conditioning with (131)I–anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome

We conducted a study to estimate the maximum tolerated dose (MTD) of (131)I–anti-CD45 antibody (Ab; BC8) that can be combined with a standard reduced-intensity conditioning regimen before allogeneic hematopoietic cell transplantation. Fifty-eight patients older than 50 years with advanced acute myel...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Pagel, John M., Gooley, Theodore A., Rajendran, Joseph, Fisher, Darrell R., Wilson, Wendy A., Sandmaier, Brenda M., Matthews, Dana C., Deeg, H. Joachim, Gopal, Ajay K., Martin, Paul J., Storb, Rainer F., Press, Oliver W., Appelbaum, Frederick R.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Hematology 2009
Teme:
Clinical Trials and Observations
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2798861/
https://ncbi.nlm.nih.gov/pubmed/19786617
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2009-03-213298
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items